NCT Number: NCT07303829
Assess the efficacy and safety of laparoscopic management of liver abscess in achieving complete drainage and clinical recovery compared to conventional open or percutaneous methods, and to:
1. To evaluate postoperative complications and recurrence rates. 2. To compare hospital stay, recovery time, and overall morbidity. 3. To determine patient outcomes and cost-effectiveness of laparoscopic intervention.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Liver abscess is a localized collection of pus within the liver parenchyma, most commonly resulting from bacterial or amoebic infection. It remains a serious clinical condition requiring timely diagnosis and effective management to prevent complications such as sepsis or rupture. Traditionally, open surgical drainage was the standard treatment for complicated or multiloculated abscesses and in cases where percutaneous drainage failed. However, advances in minimally invasive surgery have introduced laparoscopic drainage as a safer and more efficient alternative.
Laparoscopic management offers several advantages, including smaller incisions, reduced postoperative pain, shorter hospital stays, and faster recovery compared to open surgery. Moreover, it allows direct visualization of the abscess cavity, facilitates breaking of loculations, debridement of necrotic tissue, and precise placement of drainage catheters. These features enhance the completeness of drainage and reduce recurrence rates.
Recent studies have demonstrated the efficacy of laparoscopic drainage, particularly in large, complex, or multiloculated liver abscesses where percutaneous methods are unsuccessful or contraindicated. A meta-analysis of 17 studies involving 608 patients reported a recurrence rate of only 4.22% with no procedure-related mortality in the laparoscopic group. Consequently, laparoscopic drainage is now considered a step-up approach in the management algorithm of liver abscess, bridging the gap between percutaneous and open surgical techniques, while ensuring optimal clinical outcomes and reduced morbidity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laparoscopic management uses minimally invasive trocar access with camera-guided drainage and debridement, allowing precise abscess evacuation, reduced tissue trauma, faster recovery, and lower postoperative pain compared with open surgery or percutaneous drainage used in other studies.
Time frame: 30 days
Procedure-related complications (Clavien-Dindo ≥ III) within 30 days.
Time frame: 6 months.
Recurrence at the same or new site
Time frame: 30days
Successful laparoscopic drainage and drain placement
Assiut University
Other
Laproscopic Managment of Pyogenic Liver Abscess
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07579104
Abdominal Abscess, Abscess
Les Abymes, Guadeloupe
View Trial DetailsNCT01723150
Abdominal Abscess, Abscess
Singapore
View Trial DetailsNCT02032914
Abdominal Abscess, Abscess
Yangsan, Gyeongsangnam-do, South Korea
View Trial DetailsNCT01766830
Abdominal Abscess, Abscess
Phnom Penh, Cambodia
View Trial Details